blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0994858

EP0994858 - 2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.01.2007
Database last updated on 05.07.2024
Most recent event   Tooltip12.01.2007Application deemed to be withdrawnpublished on 14.02.2007  [2007/07]
Applicant(s)For all designated states
Ortho-McNeil Pharmaceutical, Inc.
U.S. Route No. 202, P.O. Box 300
Raritan, NJ 08869-0602 / US
[N/P]
Former [2000/17]For all designated states
Ortho-McNeil Pharmaceutical, Inc.
U.S. Route No.202, P.O. Box 300
Raritan, NJ 08869-0602 / US
Inventor(s)01 / WACHTER, Michael
52 North Street
Bloomsbury, NJ 08804 / US
02 / BEERS, Scott, A.
11 Kirkride Road
Flemington, NJ 08822 / US
03 / MALLOY, Elizabeth
8 Canterberry Circle
Flemington, NJ 08822 / US
04 / WU, Wei
149 West End Avenue
Somerville, NJ 08876 / US
[2000/33]
Former [2000/17]01 / WACHTER, Michael
52 North Street
Bloomsbury, NJ 08804 / US
02 / BEERS, Scott, A.
11 Kirkride Road
Flemington, NJ 08822 / US
Representative(s)Mercer, Christopher Paul, et al
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [2000/17]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date98939071.129.06.1998
[2000/17]
WO1998US13419
Priority number, dateUS19970051301P30.06.1997         Original published format: US 51301 P
[2000/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9903837
Date:28.01.1999
Language:EN
[1999/04]
Type: A1 Application with search report 
No.:EP0994858
Date:26.04.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 28.01.1999 takes the place of the publication of the European patent application.
[2000/17]
Search report(s)International search report - published on:EP28.01.1999
ClassificationIPC:C07D233/54, C07D233/84, C07D401/04, A61K31/415, A61K31/44
[2000/17]
CPC:
C07D401/04 (EP,US); C07D233/54 (KR); A61P19/02 (EP);
A61P19/10 (EP); A61P29/00 (EP); A61P43/00 (EP);
C07D233/84 (EP,US); C07D401/14 (EP,US); C07D409/14 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/17]
TitleGerman:ZUR BEHANDLUNG VON ENTZÜNDLICHEN KRANKHEITEN VERWENDBARE 2-SUBSTITUIERTE IMIDAZOLE[2000/17]
English:2-SUBSTITUTED IMIDAZOLES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES[2000/17]
French:IMIDAZOLES SUBSTITUEES EN 2 UTILISABLES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES[2000/17]
Entry into regional phase20.01.2000National basic fee paid 
20.01.2000Designation fee(s) paid 
20.01.2000Examination fee paid 
Examination procedure21.01.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.01.2000Examination requested  [2000/17]
16.04.2002Despatch of a communication from the examining division (Time limit: M06)
10.02.2003Reply to a communication from the examining division
27.04.2004Despatch of a communication from the examining division (Time limit: M06)
11.02.2005Reply to a communication from the examining division
16.02.2006Despatch of a communication from the examining division (Time limit: M06)
29.08.2006Application deemed to be withdrawn, date of legal effect  [2007/07]
29.09.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2007/07]
Request for further processing for:11.02.2005Request for further processing filed
11.02.2005Full payment received (date of receipt of payment)
Request granted
24.02.2005Decision despatched
10.02.2003Request for further processing filed
10.02.2003Full payment received (date of receipt of payment)
Request granted
26.02.2003Decision despatched
Fees paidRenewal fee
20.01.2000Renewal fee patent year 03
13.06.2001Renewal fee patent year 04
12.06.2002Renewal fee patent year 05
12.06.2003Renewal fee patent year 06
14.06.2004Renewal fee patent year 07
14.06.2005Renewal fee patent year 08
14.06.2006Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]JPS6293278  ;
 [Y]JPS6310767  ;
 [Y]JPS63239274  ;
 [X]DE2635876  (DU PONT) [X] 1,12 * page 3, line 1 - line 11 * * see page 35, examples 26,28,33,34,35,36;; claims 1,18 *;
 [X]DE2805167  (DU PONT) [X] 1,12 * page 7, line 1 * * page 26, line 30 - line 31 * * page 30, line 15 * * claims 1,14 *;
 [X]DE2805166  (DU PONT) [X] 1,12 * page 9, line 1 * * see page 33, first compound;; claims 1,16 *;
 [X]EP0004648  (CIBA GEIGY AG [CH]) [X] 1,12 * see example 1, first paragraph; example 4, third and sixth compound; example 5, compound "2-Propylthio-4(5)-phenyl-5(4)- (3-pyridyl)-imidazol"; page 5 *;
 [X]DE2823197  (SCHERING AG) [X] 1,12 * claims 16,19,22,25,55,56 *;
 [X]US4190666  (CHERKOFSKY SAUL C [US], et al) [X] 1,12 * see table I, examples 26,28,33,34,35,36 * * claims 1,29 *;
 [X]DE2856909  (SCHERING AG) [X] 1,12 * claims 30,33,36,37,42,43 *;
 [Y]EP0032113  (DU PONT [US]) [Y] 1,12 * claims 1,8; table 1 *;
 [Y]EP0043788  (SCHERING AG [DE]) [Y] 1,12 * see page 6, compound no. VI * * claims 1,16 *;
 [Y]US4330552  (CHERKOFSKY SAUL C) [Y] 1,12 * claims 1,2; table - *;
 [X]US4348404  (WHITNEY JOEL G) [X] 1,12 * see columns 7, 8 table I, examples 2,4,7,8,9,13,14,15,16,17,18,22;; claims 1,10 *;
 [X]US4372964  (WHITNEY JOEL G) [X] 1 * see table 4, example 41 * * claims 1,10 *;
 [X]AT374198B  (CIBA GEIGY AG [CH]) [X] 1 * see starting compound of example 1 * * page 11, line 9 * * page 11, line 20 *;
 [X]WO8801167  (SMITHKLINE BECKMAN CORP [US]) [X] 1,12 * see page 8, compound no. 1;; claim 1 *;
 [X]WO9204330  (SMITH KLINE FRENCH LAB [GB]) [X] 1 * see the starting compounds of the following examples: 1,4,6,7,20,28,29,32 *;
 [X]EP0522887  (RHONE POULENC RORER LTD [GB]) [X] 1 * page 8, line 30 *;
 [DX]WO9314081  (SMITHKLINE BEECHAM CORP [US]) [DX] 1-3,12 * page 40, line 14 - line 15; claims 1,13,14 *;
 [PX]US5656644  (ADAMS JERRY LEROY [US], et al) [PX] 1,12 * column 5, line 36 - line 49 * * column 12, line 65 * * column 13, line 16 - line 17 * * column 14, line 66 - line 67 * * claims 1,11 *;
 [XY]  - PATENT ABSTRACTS OF JAPAN, (19870929), vol. 11, no. 300, Database accession no. (C - 449), & JP62093278 A 19870428 (YOSHITOMI PHARMACEUT IND LTD) [XY] 1,12 * abstract *
 [Y]  - PATENT ABSTRACTS OF JAPAN, (19880617), vol. 12, no. 213, Database accession no. (C - 505), & JP63010767 A 19880118 (YOSHITOMI PHARMACEUT IND LTD) [Y] 1,12 * abstract *
 [Y]  - PATENT ABSTRACTS OF JAPAN, (19890130), vol. 13, no. 42, Database accession no. (C - 564), & JP63239274 A 19881005 (TOYAMA CHEM CO LTD) [Y] 1,12 * abstract *
 [A]  - J. P. WHITTEN ET AL., JOURNAL OF ORGANIC CHEMISTRY, (1986), vol. 51, pages 1891 - 4, XP002082708 [A] 1

DOI:   http://dx.doi.org/10.1021/jo00360a044
 [A]  - B. H. LIPSHUTZ ET AL., TETRAHEDRON LETTERS, (1986), vol. 27, no. 35, pages 4095 - 8, XP002082709 [A] 1

DOI:   http://dx.doi.org/10.1016/S0040-4039(00)84919-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.